|Exonerations in the United States 1989 through 2003|
SR Gross, K Jacoby, DJ Matheson, N Montgomery
J. Crim. l. & CrimiNology 95, 523, 2004
|Phase II trial of bicalutamide in patients with androgen receptor–positive, estrogen receptor–negative metastatic breast cancer|
A Gucalp, S Tolaney, SJ Isakoff, JN Ingle, MC Liu, LA Carey, K Blackwell, ...
Clinical cancer research 19 (19), 5505-5512, 2013
|Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment|
GA Poultsides, EL Servais, LB Saltz, S Patil, NE Kemeny, JG Guillem, ...
Journal of Clinical Oncology 27 (20), 3379, 2009
|HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing …|
S Modi, A Stopeck, H Linden, D Solit, S Chandarlapaty, N Rosen, ...
Clinical Cancer Research 17 (15), 5132, 2011
|PIK3CA mutation associates with improved outcome in breast cancer|
K Kalinsky, LM Jacks, A Heguy, S Patil, M Drobnjak, UK Bhanot, ...
Clinical cancer research 15 (16), 5049-5059, 2009
|Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial|
J Garcia-Aguilar, OS Chow, DD Smith, JE Marcet, PA Cataldo, MG Varma, ...
The Lancet Oncology 16 (8), 957-966, 2015
|Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma|
DR Feldman, MS Baum, MS Ginsberg, H Hassoun, CD Flombaum, ...
Journal of clinical oncology 27 (9), 1432, 2009
|Clinical management factors contribute to the decision for contralateral prophylactic mastectomy|
TA King, R Sakr, S Patil, I Gurevich, M Stempel, M Sampson, M Morrow
Journal of Clinical Oncology 29 (16), 2158-2164, 2011
|Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ|
U Rudloff, LM Jacks, JI Goldberg, CA Wynveen, E Brogi, S Patil, ...
Journal of Clinical Oncology 28 (23), 3762-3769, 2010
|Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast|
AV Barrio, BD Clark, JI Goldberg, LW Hoque, SF Bernik, LW Flynn, ...
Annals of surgical oncology 14 (10), 2961-2970, 2007
|Presenting features of breast cancer differ by molecular subtype|
L Wiechmann, M Sampson, M Stempel, LM Jacks, SM Patil, T King, ...
Annals of surgical oncology 16 (10), 2705-2710, 2009
|TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis|
DR Feldman, J Sheinfeld, DF Bajorin, P Fischer, S Turkula, N Ishill, S Patil, ...
Journal of Clinical Oncology 28 (10), 1706, 2010
|Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer|
S Chandarlapaty, RA Sakr, D Giri, S Patil, A Heguy, M Morrow, S Modi, ...
Clinical Cancer Research 18 (24), 6784-6791, 2012
|How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study|
A Mamtani, AV Barrio, TA King, KJ Van Zee, G Plitas, M Pilewskie, ...
Annals of surgical oncology 23 (11), 3467-3474, 2016
|Causes of death in long‐term survivors of head and neck cancer|
SS Baxi, LC Pinheiro, SM Patil, DG Pfister, KC Oeffinger, EB Elkin
Cancer 120 (10), 1507-1513, 2014
|Adolescent antecedents of high-risk driving behavior into young adulthood: substance use and parental influences|
JT Shope, PF Waller, TE Raghunathan, SM Patil
Accident Analysis & Prevention 33 (5), 649-658, 2001
|Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell …|
S Patil, RA Figlin, TE Hutson, MD Michaelson, S Négrier, ST Kim, ...
Annals of oncology 22 (2), 295-300, 2011
|Identifying vulnerable older adults with cancer: Integrating geriatric assessment into oncology practice|
A Hurria, SM Lichtman, J Gardes, D Li, S Limaye, S Patil, E Zuckerman, ...
Journal of the American Geriatrics Society 55 (10), 1604-1608, 2007
|The epichaperome is an integrated chaperome network that facilitates tumour survival|
A Rodina, T Wang, P Yan, EDG Gomes, MPS Dunphy, N Pillarsetty, ...
Nature 538 (7625), 397-401, 2016
|Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib|
PG Morris, C Chen, R Steingart, M Fleisher, N Lin, B Moy, S Come, ...
Clinical Cancer Research 17 (10), 3490, 2011